By the year 2030 the entire Baby Boomer generation will be age 65 or older. This growing number of senior Boomers will challenge the health care system, particularly when it comes to medication management and…
Read more
Patient adherence programs are continually searching for more cost-effective interventions that improve clinical outcomes. Tactics have expanded beyond outreach by phone call to digital channels including emails and SMS text messages. In a trial of…
Read more
Major mental health disorders are some of the most difficult conditions to manage. According to a retrospective analysis in Systematic Reviews, almost 450 million people are affected by mental health disorders worldwide, contributing 14% of…
Read more
Over the past decade, treatment in a variety of cancers, particularly breast cancer, chronic myelogenous leukemia, and non-small cell lung cancer, has switched from intermittent intravenous therapy to self-administered targeted oral anticancer medications (OAMs). There…
Read more
Medication non-adherence continues to be one of the most widespread issues faced by the pharmaceutical industry. According to the U.S. Centers for Disease Control, approximately 50 percent of people with chronic illnesses stop taking their…
Read more
Pharmaceutical companies have aspired to make medication adherence programs more effective for years. A report from Credit Suisse shows that increased adherence could substantially increase revenue from 2020–2026 for leading pharma companies such as Merck,…
Read more
With medication non-adherence costing the industry more than $600 billion a year, many pharmaceutical companies are creating medication adherence programs, often in conjunction with pharmacists and payers. According to Andrea Kasprzyk, Director of Sales at…
Read more
AllazoHealth, a company that uses artificial intelligence (AI) to help enterprise healthcare companies improve medication adherence and quality outcomes, has released a new study demonstrating the impact of AI on patient adherence indicators. The poster…
Read more
Summary Using artificial intelligence, AllazoHealth has identified patient groups that need the most outreach to stay adherent to their maintenance medications during the COVID-19 pandemic. COVID-19 and medication-use behaviors The worldwide devastation and fear due…
Read more
A leading pharmaceutical company engaged AllazoHealth on a multi-year project using artificial intelligence to optimize a patient support program for a major product. Overcoming an adherence challenge The pharmaceutical company faced a challenge: An estimated…
Read more